England Covers Breast Cancer Drug for 1,000 Patients
England's National Health Service will now provide a breakthrough breast cancer treatment to 1,000 women after resolving a years-long pricing dispute with AstraZeneca. The decision follows a historic U.S.-U.K. drug pricing agreement that's making lifesaving treatments more accessible.
